Is the patient New York Heart Association (NYHA) functional class II or class III?

Distinguishing NYHA Class II from Class III

The key distinction is that NYHA Class II patients experience symptoms only with ordinary physical activity, while Class III patients develop symptoms with less-than-ordinary activity—both are comfortable at rest, but the threshold for symptom provocation differs markedly. 1, 2

Defining Characteristics

NYHA Class II

• Slight limitation of physical activity 1, 2
• Comfortable at rest 3, 1
• Ordinary physical activity results in fatigue, palpitations, or dyspnea 1, 2
• Can walk more than 2 blocks on level ground and climb 1 flight of stairs at normal pace under normal conditions 3

NYHA Class III

• Marked limitation of physical activity 1, 2
• Comfortable at rest 3, 1
• Less than ordinary activity causes fatigue, palpitations, or dyspnea 1, 2
• Symptoms occur with walking only 1-2 blocks on level ground or climbing 1 flight of stairs at normal pace 3

Clinical Assessment Algorithm

To classify the patient, systematically assess their activity tolerance:

• Ask about rest symptoms: If symptoms are present at rest or with minimal exertion, this indicates Class IV, not II or III 1, 2

• Evaluate ordinary activities: Determine whether walking 2+ blocks on level ground or climbing one flight of stairs at normal pace provokes symptoms 3

  • If yes → Class II 3, 1
  • If no → proceed to next step

• Assess sub-ordinary activities: Determine if walking 1-2 blocks or less-than-ordinary exertion causes symptoms 3

  • If yes → Class III 3, 1
  • If no → Class I 1

Important Clinical Caveats

NYHA classification is highly subjective and fluctuates over time, even within the same patient depending on treatment response or disease progression 4, 5, 6. In the PARADIGM-HF trial, 58% of patients initially classified as NYHA Class I changed functional class within the first year 5.

NYHA class correlates poorly with objective measures of heart failure severity 6. Studies demonstrate substantial overlap (63-88%) in NT-proBNP levels, 6-minute walk distances, Kansas City Cardiomyopathy Questionnaire scores, and left ventricular ejection fraction between NYHA Class II and III patients 6.

Despite poor discrimination of functional capacity, NYHA class retains prognostic value: Class III patients consistently demonstrate higher mortality and hospitalization rates than Class II across multiple trials 7, 8, 6. However, the absolute risk difference varies substantially by trial and treatment era 6.

Contemporary heart failure therapies (beta-blockers, aldosterone antagonists, cardiac resynchronization therapy) do not alter the relationship between NYHA class and objective exercise parameters within each functional class 9.

The classification should be made by a healthcare provider based on patient-reported symptoms, not solely on patient self-assessment 1, 10. Consider supplementing NYHA classification with validated patient-reported outcome measures such as the Kansas City Cardiomyopathy Questionnaire, Minnesota Living with Heart Failure Questionnaire, or Chronic Heart Failure Questionnaire for more comprehensive assessment 1.